Loading clinical trials...
Loading clinical trials...
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Determine the Safety and Pharmacokinetics of AV-1 in Healthy Male and Female Adult Subjects
Conditions
Interventions
AV-1
Placebo
Locations
1
United States
PPD Austin Clinic, 7551 Metro Center Drive, Suite 200
Austin, Texas, United States
Start Date
February 4, 2020
Primary Completion Date
July 8, 2021
Completion Date
July 8, 2021
Last Updated
October 31, 2022
NCT07310264
NCT06342713
NCT07472361
NCT06823947
NCT06649110
NCT07240675
Lead Sponsor
AbViro LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions